Published in AIDS Weekly, April 26th, 2010
"A cross-sectional study was performed in ARV-naive individuals and in patients with first ARV failure. Genotypic resistance testing was performed using Viro-seq. Predicted success to first-and second-line regimens recommended by the Colombian HIV treatment guidelines was...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.